Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CASIRIVIMAB\IMDEVIMAB vs CEFADROXIL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CASIRIVIMAB\IMDEVIMAB vs CEFADROXIL: Safety Overview

Metric CASIRIVIMAB\IMDEVIMAB CEFADROXIL
Total FAERS Reports 4,248 534
Deaths Reported 137 11
Death Rate 3.2% 2.1%
Hospitalizations 1,351 136
Average Patient Age 54.3 yrs 51.6 yrs
% Female Patients 55.4% 72.5%
Manufacturer N/A Preferred Pharmaceuticals, Inc.
Route N/A ORAL